[go: up one dir, main page]

WO2013100585A3 - Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif - Google Patents

Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif Download PDF

Info

Publication number
WO2013100585A3
WO2013100585A3 PCT/KR2012/011497 KR2012011497W WO2013100585A3 WO 2013100585 A3 WO2013100585 A3 WO 2013100585A3 KR 2012011497 W KR2012011497 W KR 2012011497W WO 2013100585 A3 WO2013100585 A3 WO 2013100585A3
Authority
WO
WIPO (PCT)
Prior art keywords
same
active ingredient
cancer composition
adonis amurensis
amurensis extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/011497
Other languages
English (en)
Korean (ko)
Other versions
WO2013100585A2 (fr
Inventor
함영민
김길남
정용환
윤원종
박수영
오대주
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JEJU TECHNOPARK
Original Assignee
JEJU TECHNOPARK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JEJU TECHNOPARK filed Critical JEJU TECHNOPARK
Priority to JP2014549998A priority Critical patent/JP2015503551A/ja
Priority to CN201280064752.3A priority patent/CN104220063B/zh
Publication of WO2013100585A2 publication Critical patent/WO2013100585A2/fr
Publication of WO2013100585A3 publication Critical patent/WO2013100585A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne un extrait d'Adonis amurensis présentant une activité anticancéreuse dans une cellule et des expérimentations animales, et une composition anticancéreuse l'utilisant comme principe actif.
PCT/KR2012/011497 2011-12-26 2012-12-26 Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif Ceased WO2013100585A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2014549998A JP2015503551A (ja) 2011-12-26 2012-12-26 ミチノクフクジュソウ抽出物またはその有効物質を用いた抗癌剤組成物
CN201280064752.3A CN104220063B (zh) 2011-12-26 2012-12-26 利用细福寿草提取物或其有效物质的抗癌剂组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0142072 2011-12-26
KR20110142072 2011-12-26

Publications (2)

Publication Number Publication Date
WO2013100585A2 WO2013100585A2 (fr) 2013-07-04
WO2013100585A3 true WO2013100585A3 (fr) 2013-08-22

Family

ID=48698749

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/011497 Ceased WO2013100585A2 (fr) 2011-12-26 2012-12-26 Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif

Country Status (4)

Country Link
JP (1) JP2015503551A (fr)
KR (1) KR101530910B1 (fr)
CN (1) CN104220063B (fr)
WO (1) WO2013100585A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110372808B (zh) * 2019-07-30 2020-11-03 玛莉艾丝(广东)生命科技有限公司 一种祛斑美白活性多糖和用途
CN110343187B (zh) * 2019-07-30 2020-07-17 广州市爱百伊生物技术有限公司 一种天然多糖及祛斑美白用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001206819A (ja) * 2000-01-24 2001-07-31 Sansho Seiyaku Co Ltd 美白化粧料
KR20030080459A (ko) * 2002-04-08 2003-10-17 송호엽 당뇨병제 및 제조방법
KR20110001538A (ko) * 2009-06-30 2011-01-06 한국콜마 주식회사 항산화 및 미백 활성을 갖는 꽃 혼합 추출물 및 그 추출방법 및 그 꽃 혼합 추출물을 함유하는 화장료 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001206819A (ja) * 2000-01-24 2001-07-31 Sansho Seiyaku Co Ltd 美白化粧料
KR20030080459A (ko) * 2002-04-08 2003-10-17 송호엽 당뇨병제 및 제조방법
KR20110001538A (ko) * 2009-06-30 2011-01-06 한국콜마 주식회사 항산화 및 미백 활성을 갖는 꽃 혼합 추출물 및 그 추출방법 및 그 꽃 혼합 추출물을 함유하는 화장료 조성물

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KI HWAN, BAE ET AL.: "of angiogenesis inhibitors from Korean plants (1)", KOREAN JOURNAL OF PHARMACOGNOSY, vol. 31, no. 3, 2000, pages 320 - 324 *
YOU, YOUNG-JAE ET AL.: "Inhibitory effect of Adonis amurensis components on tube-like formation of human umbilical venous cells", PHYTOTHERAPY RESEARCH, vol. 17, 2003, pages 568 - 570 *

Also Published As

Publication number Publication date
WO2013100585A2 (fr) 2013-07-04
CN104220063B (zh) 2016-06-08
CN104220063A (zh) 2014-12-17
KR101530910B1 (ko) 2015-06-23
KR20130074768A (ko) 2013-07-04
JP2015503551A (ja) 2015-02-02

Similar Documents

Publication Publication Date Title
WO2013102144A3 (fr) Variants du polypeptide ph20, formulations en contenant et leurs utilisations
WO2014179629A3 (fr) Compositions et procédés
WO2012056457A3 (fr) COMPOSITIONS ET PROCÉDÉS D'ACTIVATION D'EXPRESSION PAR UN ARNmi ENDOGÈNE SPÉCIFIQUE
EA201500582A1 (ru) Тройные фунгицидные смеси
HK1208216A1 (en) Drug-conjugates, conjugation methods, and uses thereof
WO2009089494A3 (fr) Compositions pharmaceutiques
WO2012077077A8 (fr) Mélanges fongicides
MX2016008448A (es) Conjugados de var2csa-farmaco.
WO2012129341A3 (fr) Détection d'une maladie chez les plantes
CR20140421A (es) Cepa plaguicida de flavobacterium y composiciones bioactivas, metabolitos y usos de la misma
HK1202549A1 (en) Donepezil pamoate, preparation method and its use
IL220894A (en) Combinations of active substances containing dihydroporone and abamctin
FR2967572B1 (fr) Composition cosmetique comprenant un polyphenol en association avec un sucre
PL2667719T3 (pl) Kompozycja pestycydowa zawierająca siarkę, środek owadobójczy i agrochemiczną substancję pomocniczą
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
WO2012051328A3 (fr) Pesticides à activité tensioactive élevée
EP3067059A4 (fr) Composition pharmaceutique pour prévenir ou traiter des maladies thyroïdiennes, contenant de l'extrait de fruit de lonicera caerulea l. var. edulis comme principe actif
WO2011122872A3 (fr) Composition comprenant du coumestrol ou un extrait de fèves contenant du coumestrol
WO2012002730A3 (fr) Composition hydratante et de blanchiment de la peau contenant des extraits de venin d'abeille
ZA201306090B (en) Pesticide composition comprising sulphur,an acaricide and an agrochemical excipient
WO2014044342A8 (fr) Carbonate d'hydroxyde de magnésium en tant qu'excipient dans des préparations renfermant un principe actif
WO2013029011A3 (fr) Procédés et compositions renfermant un peptide dérivé de l'extrémité c terminale de bax
GT200900006A (es) Derivados de piridazina novedosos
WO2009047434A3 (fr) Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant
IL225440A (en) Cyclohexane derivatives, preparations containing them and their uses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12861795

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2014549998

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 12861795

Country of ref document: EP

Kind code of ref document: A2